查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲微载体市场预测至 2030 年 - 区域分析 - 按产品、设备、应用和最终用户
市场调查报告书
商品编码
1494455

欧洲微载体市场预测至 2030 年 - 区域分析 - 按产品、设备、应用和最终用户

Europe Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 101 Pages | 订单完成后即时交付

价格

欧洲微载体市场预计将从2022年的4.1719亿美元成长到2030年的10.3552亿美元。

微载体製造商的策略性倡议和创新产品推动欧洲微载体市场

在微载体市场运营的公司专注于策略发展，例如合作、扩张、协议、伙伴关係和新产品发布，这有助于他们提高销售额、扩大地理覆盖范围并增强能力，以满足比现有客户群更大的需求。提到了微载体市场的一些值得注意的发展，2023年10月，可乐丽有限公司开发了用于再生医学细胞培养的PVA水凝胶微载体。该产品计划于 2024 年 1 月在日本和海外推出，首先从美国推出。 2023 年 6 月，帝人前沿推出了新型非织造微载体，可实现快速、大规模、高品质的细胞培养。新型非织造微载体结合了帝人前沿的专有纤维工艺和非织造设计技术，以及日本福井大学工程学院的纤维相关生物医学专业知识。 2023 年 10 月，Semarion 推出了 SemaCyte 微载体平台的早期采用者计画。 Semarion 开发的 SemaCytes 是利用微晶片製造技术、奈米磁性和智慧材料创建的细胞载体材料。这些分析微载体是扁平的，具有超小型磁控孔的功能，可将贴壁细胞的小集落带入悬浮液中，以改善基于细胞的实验。 2021 年 1 月，赛默飞世尔科技公司收购了 Groupe Novasep SAS 旗下位于比利时的病毒载体製造业 Henogen SA。 Henogen 为生物技术公司和大型生物製药客户提供疫苗和治疗药物製造服务。透过此次收购，赛默飞世尔科技扩大了在细胞和基因疫苗及疗法领域的能力。 2020年11月，新加坡-麻省理工学院科技联盟（SMART）的研究人员开发了一种用于大规模细胞生产和细胞扩增的新型微载体。使用这种微载体将使企业能够以比传统方法更具成本效益的方式获得更高的产量，同时减少细胞修復过程中涉及的步骤数量。 SMART 新开发的可溶性明胶微载体可用于细胞扩增，以治疗各种疾病，包括骨和软骨缺陷以及移植物抗宿主疾病，即对外来骨髓和细胞的排斥。因此，推出PVA水凝胶微载体、非织造微载体和SemaCyte微载体平台等产品，并透过合作和伙伴关係启动新业务以维持市场竞争力，将为微载体市场创造重大成长机会。

欧洲微载体市场概况

欧洲在全球微载体市场中占有重要份额。该地区的市场成长归因于发达的医疗保健产业和基础设施，以及德国、英国、法国、罗马尼亚和葡萄牙等经济体的医疗保健支出显着较高。为了提高生物製药生产力，对细胞培养设备的进步的需求不断增长，并且不断进行具有可靠结果的研究，从而催生了自动化细胞培养过程和系统。此外，合约製造和研究设施正在大规模运营，以满足欧洲医疗保健产业对先进治疗方案不断增长的需求。德国的製药业由中小企业组成；在全球製药工业规模最大的国家中排名第四。根据国际贸易管理局 (ITA) 的数据，2019 年德国医药市场规模约为 625 亿美元。该行业的成长是由研发投资增加和专利申请数量增加等因素所推动的。 Paul-Ehrlich-Institut (PEI) 联邦疫苗和生物医学产品研究所在流感疫苗进入德国市场之前对其进行批量测试。德国拥有强大的製药业，尤其註重研发。根据 NecstGen 的报告，2021 年德国正在进行超过 29 项评估 CAR 修饰免疫细胞的活跃临床试验，其中大部分生产涉及 CAR-T 细胞。此外，迄今为止，德国已开展了 50 多项基因疗法临床研究。

欧洲微载体市场营收及 2030 年预测（百万美元）

欧洲微载体市场细分

欧洲微载体市场分为产品、设备、应用、最终用户和国家。

根据产品，欧洲微载体市场分为微载体珠和培养基和试剂。 2022 年，微载体珠细分市场在欧洲微载体市场中占有更大份额。

在设备方面，欧洲微载体市场分为生物反应器、培养容器等。 2022 年，生物反应器领域占据欧洲微载体市场的最大份额。

根据应用，欧洲微载体市场分为生物製药生产、细胞和基因治疗、组织工程和再生医学等。到2022年，生物製药生产领域在欧洲微载体市场中占据最大份额。

根据最终用户，欧洲微载体市场分为製药和生物技术公司、合约研究组织和合约製造组织以及学术和研究机构。 2022 年，製药和生物技术公司领域占据欧洲微载体市场的最大份额。

根据国家/地区，欧洲微载体市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲微载体市场占据主导地位。

Teijin Ltd、Bio-Rad Laboratories Inc、denovoMATRIX GmbH、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、Percell Biolytica AB、Asahi Kasei Corp 和 Polysciences Inc 是欧洲微载体市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲微载体市场 - 主要产业动态

  • 主要市场驱动因素：
    • 随着癌症和传染病发病率的上升，对细胞疗法的需求
    • 外包细胞和基因治疗製造越来越受欢迎
    • 再生医学的采用激增
  • 市场限制
    • 生物製剂和细胞疗法的高成本
  • 市场机会
    • 微载体製造商的策略性倡议和创新产品
  • 未来的趋势
    • 细胞和基因治疗製造服务的自动化
  • 影响分析

第 5 章：微载体市场 - 欧洲市场分析

  • 微载体市场收入，2022 - 2030

第 6 章：欧洲微载体市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年按产品分類的微载体市场收入份额 (%)
  • 微载体珠
  • 介质和试剂

第 7 章：欧洲微载体市场 - 收入和 2030 年预测 - 按设备

  • 概述
  • 2022 年及 2030 年按设备分類的微载体市场收入份额 (%)
  • 生物反应器
  • 培养容器
  • 其他的

第 8 章：欧洲微载体市场 - 2030 年收入和预测 - 按应用

  • 概述
  • 2022 年和 2030 年按应用分類的微载体市场收入份额 (%)
  • 生物製药生产
  • 细胞和基因治疗
  • 组织工程与再生医学
  • 其他的

第 9 章：欧洲微载体市场收入和 2030 年预测 - 最终用户

  • 概述
  • 欧洲微载体最终用户市场占有率 - 2022 年和 2030 年 (%)
  • 製药和生物技术公司
    • 概述
    • 製药和生物技术公司：微载体市场 - 收入和 2030 年预测
  • 合约研究组织和合约製造组织
    • 概述
    • 合约研究组织和合约製造组织：微载体市场 - 收入和 2028 年预测
  • 学术及研究机构
    • 概述
    • 学术和研究机构：微载体市场 - 收入和 2028 年预测

第 10 章：欧洲微载体市场收入和 2030 年预测 - 国家分析

    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 欧洲其他地区

第 11 章：微载体市场-产业格局

  • 概述
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • denovoMATRIX GmbH
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Percell Biolytica AB
  • Asahi Kasei Corp
  • Polysciences Inc

第 13 章：附录

Product Code: BMIRE00029977

The Europe microcarriers market is expected to grow from US$ 417.19 million in 2022 to US$ 1,035.52 million by 2030. It is estimated to record a CAGR of 12.0% from 2022 to 2030.

Strategic Initiatives and Innovative Products by Microcarrier Manufacturers Drive Europe Microcarriers Market

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned, In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US. In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier's proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan. In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments. In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category. In November 2020, researchers from the Singapore-MIT Alliance for Science and Technology (SMART) developed a novel microcarrier for large-scale cell production and cell expansion. Employing this microcarrier would allow businesses to have higher yields in a more cost-effective way than traditional methods while lowering the number of steps involved in the cell retrieval process. This newly developed dissolvable Gelatin microcarrier from SMART can be used in cell expansion for treating various ailments, including bone and cartilage defects, and graft vs. host disease, i.e., the rejection of foreign bone marrow and cells. Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Europe Microcarriers Market Overview

Europe holds a significant share of the global microcarrier market. The market growth in this region is attributed to the well-developed healthcare sector and infrastructure, and the significantly high healthcare spending in economies such as Germany, the UK, France, Romania, and Portugal. The increasing demand for advancements in cell culture equipment for better biopharmaceutical productivity and ongoing research with reliable outcomes are resulting in automated cell culture processes and systems. In addition, contract manufacturing and research facilities are operating on huge scales to meet the ever-increasing demands of the European healthcare sector for advanced treatment options. The pharmaceutical industry in Germany consists of small and mid-sized companies; it ranks fourth among the countries with the largest pharmaceutical industries in the world. As per the International Trade Administration (ITA), the pharmaceutical market in Germany accounted for ~US$ 62.5 billion in 2019. The country is most likely to remain one of the most desirable destinations for the global pharmaceutical industries over the coming years in terms of manufacturing and supply. The industry's growth is driven by factors such as increasing investments in R&D and the elevating number of patent applications. The Federal Institute for Vaccines and Biomedical Products at Paul-Ehrlich-Institut (PEI) conducts the batch testing of influenza vaccines before their release into the German market. Germany has a strong pharmaceutical industry with a notable R&D focus. As per a NecstGen report, more than 29 active clinical trials evaluating CAR-modified immune cells were underway in Germany in 2021, and the majority of the production involved CAR-T cells. Also, over 50 clinical studies have been conducted in gene therapy in Germany so far.

Europe Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

Europe Microcarriers Market Segmentation

The Europe microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the Europe microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Europe microcarriers market in 2022.

In terms of equipment, the Europe microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Europe microcarriers market in 2022.

Based on application, the Europe microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Europe microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the Europe microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Europe microcarriers market in 2022.

Based on country, the Europe microcarriers market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Europe microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - Europe Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 Europe Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. Europe Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 Europe Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Europe: Microcarriers Market, by Country
      • 10.1.2.1 Germany
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
        • 10.1.2.1.3 Germany: Microcarriers Market, by Product
        • 10.1.2.1.4 Germany: Microcarriers Market, by Equipment
        • 10.1.2.1.5 Germany: Microcarriers Market, by Application
        • 10.1.2.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 Germany: Microcarriers Market, by End User
      • 10.1.2.2 UK
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 UK: Microcarriers Market, by Product
        • 10.1.2.2.4 UK: Microcarriers Market, by Equipment
        • 10.1.2.2.5 UK: Microcarriers Market, by Application
        • 10.1.2.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 UK: Microcarriers Market, by End User
      • 10.1.2.3 France
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 France: Microcarriers Market, by Product
        • 10.1.2.3.4 France: Microcarriers Market, by Equipment
        • 10.1.2.3.5 France: Microcarriers Market, by Application
        • 10.1.2.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 France: Microcarriers Market, by End User
      • 10.1.2.4 Italy
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
        • 10.1.2.4.3 Italy: Microcarriers Market, by Product
        • 10.1.2.4.4 Italy: Microcarriers Market, by Equipment
        • 10.1.2.4.5 Italy: Microcarriers Market, by Application
        • 10.1.2.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.4.6 Italy: Microcarriers Market, by End User
      • 10.1.2.5 Spain
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 Spain: Microcarriers Market, by Product
        • 10.1.2.5.4 Spain: Microcarriers Market, by Equipment
        • 10.1.2.5.5 Spain: Microcarriers Market, by Application
        • 10.1.2.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.5.6 Spain: Microcarriers Market, by End User
      • 10.1.2.6 Rest of Europe
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Europe: Microcarriers Market, by Product
        • 10.1.2.6.4 Rest of Europe: Microcarriers Market, by Equipment
        • 10.1.2.6.5 Rest of Europe: Microcarriers Market, by Application
        • 10.1.2.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.6.6 Rest of Europe: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 denovoMATRIX GmbH
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Sartorius AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Danaher Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Corning Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Eppendorf SE
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Percell Biolytica AB
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Asahi Kasei Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polysciences Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. Germany Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. Germany Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. Germany Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. Germany Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. UK Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. UK Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. UK Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. UK Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. France Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. France Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. France Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. France Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Italy Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Italy Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Italy Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Italy Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. Spain Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Spain Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. Spain Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. Spain Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Rest of Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Rest of Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. Recent Organic Growth Strategies in Microcarriers Market
  • Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. Germany: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Italy: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)